
glyset
Pharmaranks rates Glyset 3.2/5 for recall safety — an independent score from its FDA recall history and its manufacturer's record. Glyset (Miglitol) is an alpha-glucosidase inhibitor used to treat Type 2 Diabetes Mellitus.
Miglitol · by Pfizer
Based on 1 source · Recall-safety score from FDA recall history — this product's own recalls and its manufacturer's record. Not an efficacy or quality rating. methodology →
Key facts
- Active ingredient
- Miglitol
- Drug class
- Alpha-Glucosidase Inhibitor
- Form
- Tablet
- Strength
- Miglitol 100MG · Miglitol 25MG · Miglitol 50MG
- Type
- Prescription (Rx)
- Brand or generic
- Brand-name
- May treat
- type 2 diabetes mellitus
- Manufacturer
- Pfizer
- What the pharmacy pays
- ~$52.64 for 30 — not your price
- FDA application
- NDA020682
- Availability
- Discontinued (per FDA)
Drug class
May treat (source: NIH RxClass)
Dosage forms
Tablet
The forms currently marketed in the U.S., per the FDA National Drug Code Directory.
Ways to save
Ask for the generic
Same active ingredient, far cheaper. Is there a generic? →
Request a 90-day supply
Bulk fills usually lower the per-dose price vs monthly refills.
Use copay cards
Manufacturer copay cards & patient-assistance programs — especially for brand drugs.
Compare alternatives
A same-class option may cost less. See alternatives →
Frequently asked questions
- What does Glyset treat?
- Glyset (Miglitol) may be used to treat type 2 diabetes mellitus, based on NIH RxClass drug-classification data (conditions a drug may treat — not a verbatim copy of the FDA-approved label). This is general reference, not medical advice.
- How is Glyset rated?
- pharmaranks gives Glyset a composite score of 3.2 out of 5, currently based on 1 weighted source (FDA regulatory recall-safety data weighted highest). See our methodology at /how-we-rate.
- How much does Glyset cost?
- Nobody can tell you what you will pay — your price is set by your insurer's formulary, your deductible and the pharmacy's markup, and none of those are published. What IS published is what the pharmacy paid to acquire it: about $52.64 for 30, per the CMS NADAC survey. Treat that as the floor, not the quote — ask the pharmacist for the cash price as well as your copay, because for cheap generics the cash price often wins.
- Is there a coupon or discount for Glyset?
- pharmaranks is an independent ratings site, not a pharmacy — we don't issue coupons or sell Glyset. To pay less, ask your prescriber or pharmacist whether a generic equivalent exists, check the manufacturer's copay/savings card and patient-assistance program, and compare a pharmacy discount card against your insurance copay. Prices vary by pharmacy, insurance, and location, so always confirm at the counter. This is general reference, not medical or financial advice.
- Who makes Glyset?
- Glyset is marketed by Pfizer. You can see Pfizer's full profile, rating, and other products on pharmaranks.
- Is Glyset a brand-name or generic drug?
- Glyset is a brand-name product with the active ingredient Miglitol.
- Is Glyset available over the counter?
- No. Glyset is a prescription (Rx) medication in the US — you need a prescription from a licensed clinician (in person or via telehealth); it isn't sold over the counter. For some conditions there are OTC alternatives — ask your pharmacist.
- What forms does Glyset come in?
- Glyset is currently marketed as tablet, per the FDA's National Drug Code Directory.
- What class of drug is Glyset?
- Glyset is classified as alpha-glucosidase inhibitor, per the FDA's Established Pharmacologic Class.
- Is Glyset FDA-registered?
- Glyset is on record with the U.S. FDA under application number NDA020682. You can verify this on its official FDA label.
- Has Glyset been recalled by the FDA?
- Glyset has no FDA recalls recorded under its own application in the openFDA enforcement database. Its recall-safety score reflects its manufacturer's overall recall record. This is general reference, not medical advice — check the FDA recall database for the latest alerts.
- Is Glyset safe?
- There's no single safe-or-not verdict. pharmaranks gives Glyset a recall-safety score of 64/100, based on its FDA recall history (no recalls under its own FDA application) — not an efficacy or side-effect rating. Review its FDA-label side effects and warnings before use, and always consult a licensed professional.
Information is sourced from public FDA regulatory data. Provided for general reference only — not medical advice. Always consult a licensed professional and the current prescribing information.
Reviews
No reviews yet. Be the first to write one.
People also viewed
tradjenta
Linagliptin
adlyxin
Lixisenatide
admelog
Insulin Lispro
admelog solostar
Insulin Lispro
awiqli flextouch
Insulin Icodec
brynovin
Sitagliptin Hydrochloride
Compare Glyset head-to-head
Browse medications A–Z
Research products from A to Z, compare independent ratings, and find alternatives.
glyset
64/100